ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification and characterization of ferroptosis-related genes in therapy-resistant gastric cancer

Yu, Jieli; Li, Hua; Huang, Can; Chen, Huoguodepartment
Medicine (Baltimore)2024-5-17DOI: 10.1097/MD.0000000000038193
1阅读
引用收藏
分享

摘要

Therapy resistance in gastric cancer poses ongoing challenges, necessitating the identification of ferroptosis-related genes linked to overall survival for potential therapeutic insights. The purpose of the study was to identify ferroptosis-related genes contributing to therapy resistance in gastric cancer and explore their associations with overall survival. Differentially expressed ferroptosis-related genes were identified in therapy-resistant versus therapy-responsive gastric cancer patients. Hub genes were selected from these genes. Enrichment analysis focused on oxidative stress and ROS metabolism. Validation was conducted in a TCGA stomach adenocarcinoma dataset. A hub gene-based risk model (DUSP1/TNF/NOX4/LONP1) was constructed and assessed for overall survival prediction. Associations with the tumor immune microenvironment were examined using the ESTIMATE algorithm and correlation analysis. Ten hub genes were identified, enriched in oxidative stress and ROS metabolism. Validation confirmed their aberrant expressions in the TCGA dataset. The hub gene-based risk model effectively predicted overall survival. High G6PD/TNF expression and low NOX4/SREBF1/MAPK3/DUSP1/KRAS/SIRT3/LONP1 expression correlated with stromal and immune scores. KRAS/TNF/MAPK3 expression positively correlated with immune-related SREBF1/NOX4 expression. DUSP1/NOX4/SREBF1/TNF/KRAS expression was associated with immune cell infiltration. The hub gene-based risk model (DUSP1/TNF/NOX4/LONP1) shows promise as an overall survival predictor in gastric cancer. Ferroptosis-related hub genes represent potential therapeutic targets for overcoming therapy resistance in gastric cancer treatment.

相关
加载中…
  • Investigation of two ferroptosis-related molecular subtypes and biomarkers in the progression of gastric adenocarcinoma
    Lu, Weiqun; Wu, Wei; Wang, Xiaolong; Lv, Zhuo; Han, Yongjun; Wei, Lili; Li, Liping; Ji, Gang*All Life, 2022, 15(1): 537-546.
  • Ferroptosis Patterns Correlate with Immune Microenvironment Characterization in Gastric Cancer
    Jiang, Xiaotao; Liu, Fan; Liu, Peng; Yan, Yanhua; Lan, Shaoyang; Zhuang, Kunhai; Liu, Yufeng; Jiang, Kailin; Huang, Yuancheng; Nie, Kechao; Zheng, Zhihua; Pan, Jinglin; Zheng, Junhui; Liu, Fengbin; Xu, Shijie; Li, Peiwu*; Wen, Yi*International Journal of General Medicine, 2021, 14: 6573-6586.被引 3
  • Identification and validation of stemness-based and ferroptosis-related molecular clusters in pancreatic ductal adenocarcinoma
    Ruan, Shiye; Wang, Hailiang; Zhang, Zhongyan; Yan, Qian; Chen, Yubin; Cui, Jinwei; Huang, Shanzhou; Zhou, Qi*; Zhang, Chuanzhao*; Hou, Baohua*Translational Oncology, 2024, 41: 101877.
查看全部 →

发表信息

论文状态
公开发表
期刊
Medicine (Baltimore)
发表日期
2024-05-17
卷期
第 103 卷, 第 20 期
页码
e38193
DOI
10.1097/MD.0000000000038193
成果收录
PUBMED

作者

  • Y

    Yu, Jieli (第一作者)

    department

  • L

    Li, Hua

    department

查看全部 4 位作者收起作者
  • H

    Huang, Can

    department

  • C

    Chen, Huoguo

    department

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417